WELCOME TO
BSG LIVE’25
Connect • Learn • Innovate
Industry Symposia - Eli Lilly and Company
Lilly promotional symposium
Going Beyond Symptom Relief: Targeting Deep Disease Control in IBD
Tuesday 23rd June – 10:40 - 11:10
In this session, we will review emerging endpoints in disease control in IBD. We will review the long-term efficacy of treatments, along with the potential clinical relevance of these findings.
Speakers:
Dr Alissa Walsh, Oxford University Hospitals NHS Trust
Dr Nik Plevris – NHS Lothian
This meeting has been developed, organised and funded by Eli Lilly and Company. Lilly products will be discussed in this meeting.
Intended for Healthcare Professionals in the United Kingdom.
CMAT-29660 May 2026
